Manufacturer of

Ranitidine

Famotidine

Telmisartan

Globally Approved Facility

US-FDA, EU-GMP (AEMPS), WHO-GMP certified manufacturing unit providing high-quality API – Ranitidine HCl for more than three decades.

Launch of New APIs

With COVID-19 presenting global challenges, we now manufacture APIs Famotidine, Levetiracetam, and Telmisartan.

Well Equipped Research Laboratory

ORCHEV has established well-equipped laboratories for quality product and contract manufacturing.

Welcome to Orchev Pharma Pvt. Ltd.

Orchev Pharma Pvt. Ltd. established in 1989 as a single site operation, Orchev has a reputation for manufacturing Ranitidine as per the latest USP/EP/BP/IP. Its growth has been fuelled by relationships with global market participants that want to conduct business with a company that maintains high levels of quality.

Since the beginning of operations in 1989, Orchev Pharma Pvt. Ltd. has quickly emerged as a leading manufacturer of high-quality of pharmaceutical raw material in the Gujarat State of India. What separates Orchev from other trusted manufacturers is not only that we manufacture excellent quality APIs and intermediates; provide excellent services to customers, which additionally includes small scale manufacturing of product for trial supply and full-scale manufacture for commercial supply. Orchev employs chemists, chemical engineers, microbiologists of the highest caliber and maintains the quality assurance standard.

With the aim to manufacture high-quality Ranitidine, Famotidine, Telmisartan, and Levetiracetam, our organization has believed in continuous development and evaluation.

With our proven experience and expertise; Orchev manufactures under (fully complies with) the standards of USFDA, CEP and WHO-GMP. We have been audited & Approved by EDQM, AEMPS(Spain), Korean Food and Drug Administration (KFDA), and COFEPRIS – Mexican Health Authority. Orchev Pharma Pvt. Ltd. is an ISO 9001:2015 company. In August 2018, the USFDA inspected our manufacturing facility which was cleared with ZERO 483.

What’s new:

2023 a year of Events for API – Famotidine:

ORCHEV’s US-DMF#036764 for Famotidine passed CA and the customer received approval of ANDA in October 2023.
Received CEP 2022-307 for Famotidine in August 2023 from EDQM.
Chinese DMF # Y20220000306 for Famotidine registration successful with IDL Status “A” in December 2023.